Discrimination of healthy and glaucomatous eyes based on the ocular pulse amplitude: A diagnostic case-control study by Robert, Y C A et al.








Discrimination of healthy and glaucomatous eyes based on the ocular pulse
amplitude: A diagnostic case-control study
Robert, Y C A ; Wild, A ; Kessels, A G ; Backes, W H ; Zollinger, A ; Bachmann, L M
Abstract: By measuring the ocular pulse amplitude (OPA), the dynamic contour tonometer (DCT)
assesses intraocular pressure (IOP). Hypothesizing that OPA is characteristic for the IOP when considered
with the systemic arterial blood pressure, we assumed the ratio of ocular and arterial pulsation amplitudes
is larger in glaucoma patients. Bi-ocular DCT-OPA assessment was synchronized with arterial pulsations
using Finapres® technology, thereby enabling blood pressure determination for each corresponding IOP
value every 0.01 s for 12 s. Based on measurements and calculations in 10 healthy subjects and 11
glaucoma patients, we conclude that the ratio of the OPA and blood pressure variances is a strong
glaucoma diagnostic indicator, thereby justifying further investigation.
DOI: https://doi.org/10.1159/000334616





Robert, Y C A; Wild, A; Kessels, A G; Backes, W H; Zollinger, A; Bachmann, L M (2012). Discrimination
of healthy and glaucomatous eyes based on the ocular pulse amplitude: A diagnostic case-control study.
Ophthalmic Research, 48(1):1-5.
DOI: https://doi.org/10.1159/000334616
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Original Paper 
 Ophthalmic Res 2012;48:1–5 
 DOI: 10.1159/000334616 
 Discrimination of Healthy and Glaucomatous
Eyes Based on the Ocular Pulse Amplitude:
A Diagnostic Case-Control Study 
 Yves C.A. Robert a    Andreas Wild d    Alfons G. Kessels f    Walter H. Backes e    
Andreas Zollinger b    Lucas M. Bachmann c 
 a  Eye Department and  b  Department of Anesthesiology and Intensive Care Medicine, Triemli Hospital,
 c  Horten Centre, University of Zurich,  Zurich , and  d  Eye Clinic Pallas,  Olten , Switzerland; Departments of
 e  Radiology and  f  Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, 
 Maastricht , The Netherlands
 
 Introduction 
 When glaucoma is associated with anatomic anoma-
lies in the anterior segment, diagnosis and follow-up of 
the disease primarily rely on tonometry and functional 
tests. However, most types of glaucomas, i.e. primary 
open-angle glaucoma and low-tension glaucoma, do not 
show any apparent anatomic landmark in the anterior 
segment and often present normal tonometric values. 
This makes discrimination difficult.
 The ocular pulse amplitude (OPA) is a physiological 
parameter  [1–3] . It originates from the heartbeat and 
travels as a pressure wave along the arterial branches to 
the ciliary arteries and the choroid  [2, 3] . As it enters the 
eye, the wave demonstrates a purely arterial behavior. It 
eventually reaches the sclera/cornea and the aqueous hu-
mor. In the chamber angle, the aqueous humor outflow 
through the trabeculum attenuates the pulse wave. This 
damping effect depends on the outflow resistance  [4] . 
Consequently, OPA measurements should be able to de-
tect differences in trabecular outflow characteristics be-
tween normal and glaucomatous eyes.
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 Dynamic contour tonometry (DCT) measures the in-
traocular pressure (IOP) and its variation directly and 
without deformation of the eye, and thereby provides a 
raw signal of the pressure curve  [1] . Any alteration from a 
pure arterial signal can be seen by comparison with a sim-
ilar peripheral arterial pulse wave, e.g. at the fingertip  [5] . 
We therefore hypothesized that the increased outflow re-
sistance in glaucoma patients modifies ocular pulsations, 
as measured by DCT. Consequently, we presumed that the 
ratio of the ocular pulsation amplitude to the arterial pul-
sation amplitude would be larger in healthy subjects than 
in glaucoma patients and thus investigated the diagnostic 
performance of this ratio in detecting glaucoma.
 Material and Methods 
 Participants 
 The Ethics Committee of the Stadtspital Triemli approved this 
study, which followed strictly the tenets of the Declaration of Hel-
sinki. All participants provided oral and written informed con-
sent. We recruited a convenience sample of 11 glaucoma patients 
attending the Triemli outpatient eye clinic and 10 healthy subjects 
recruited from house staff. All participants underwent measure-
ments in a standardized fashion. Two weeks prior to the test, all 
ocular medication in the glaucoma group was stopped.
 Slitlamp examination of the anterior and posterior segment 
was done routinely, without touching the eye. In order to avoid 
artifacts, the chamber angle of the patients was not examined dur-
ing study measurements. In previous examinations, the visual 
field had been evaluated using the Octopus 901, Program G1 or 
similar. Interpretation of the fields adhered to the guidelines of 
the European Glaucoma Society  [6] .
 Tonometry 
 First, Goldmann applanation tonometry  [7] was performed 
with 3 measurements for each eye, the right eye first, and the 
mean was taken; afterwards, the DCT was measured. Goldmann 
applanation tonometry measurement served as an internal qual-
ity control. The measurement was repeated, if necessary, and con-
sidered valid if a pulse curve was registered over a period of at least 
12 s and if the value corresponded to the Goldmann applanation 
tonometry value.
 Arterial Pulse Measurement  
 Before the IOP measurement and with the patient sitting at the 
slitlamp, the third finger of the left hand was armed with the cuff 
of a noninvasive, beat-to-beat cardiovascular Finometers PRO 
monitor (BMEYE BV, Amsterdam, the Netherlands). The device 
measures the arterial blood pressure continuously. The method is 
based on the dynamic pulsatile unloading of the finger arterial 
walls. The width of an artery under the cuff wrapped around a 
finger is kept constant (‘clamped’) at a certain diameter, in spite 
of the changes in arterial pressure during each heart beat. Chang-
es in diameter, i.e. during systole, are detected immediately by an 











































 Fig. 1. Sample of Fourier analysis for finger 
and ocular pulsation of one patient. 
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and a rapid pressure servo controller increases cuff pressure to 
prevent diameter change. Peak systolic pressure is reached when 
the amplitude of the pulsations in the plethysmogram is largest 
 [5] . Sampling frequency was 100 Hz. This system was then con-
nected to the monitor. An electronic trigger mechanism, espe-
cially designed for our purpose, was attached to the tonometer 
ensuring the temporal attribution of the signals from the tonom-
eter and the monitor. This guaranteed an identical time scale for 
the two signals. A simultaneous measurement time of at least
12 s was required in order to consider a measurement valid.
 Statistical Analysis 
 We investigated the diagnostic performance using two param-
eters. First, we used the standard deviation of each of the ocular 
and the arterial pulse amplitude signals as an approximation for 
the amplitudes of the ocular and arterial pressure, which is easily 
determined by standard software. With these two standard de-
viations, the ratio was calculated as a diagnostic parameter. Sec-
ond, for each of the individual signals (ocular and arterial pres-
sure), we performed a fast Fourier transform Fourier spectral 
analysis  [8] . From these, we calculated the ratio of the amplitudes 
of the first component ( fig.  1 ). The diagnostic performance of 
both ratios was investigated with receiver operating characteristic 
curves and areas under the curves  [9, 10] .
 Results 
 There were 6 (55%) males in the glaucoma group, while 
there were only females in the control group. The mean 
age of the glaucoma patients was 67.1 years (SD 12.0) and 
43.5 years (SD 11.2) in the controls. The mean IOP [18.8 
mm Hg (SD 3.9) vs. 18.3 mm Hg (SD 2.3)] and the mean 
systemic arterial pressure [94.8 mm Hg (SD 30.0) vs. 81.6 
mm Hg (SD 25.4)] were quite similar. Five out of 11 glau-
coma patients had systemic hypertension and were tak-
ing antihypertensive drugs at the time of measurements. 
Details are given in  tables 1 and  2 .
 In total, we obtained 6,112 measurements of ocular 
pressure and systemic blood pressure of glaucoma pa-
tients (between 99 and 1,141 measurements per patient) 
and 4,994 measurements (between 404 and 648 measure-
ments per subject) of controls.
 Figure 2 displays a box plot distribution of standard 
deviations of the pressure/pulse ratio derived for glau-
coma patients and healthy controls. As shown in  figure 3 , 
the discriminative capacity, as quantified with the area 
under the receiver operating characteristic curve, derived 
from the ratio of standard deviations of IOP and system-
ic pressure, was as high as 0.81 (95% CI 0.58–1.00). The 
diagnostic performance of the first Fourier Spectral 
Analysis component of that ratio was even higher at 0.85 
(95% CI 0.66–1.00).
 Discussion 
 Discrimination of early primary open-angle glaucoma 
from normal subjects is difficult due to long-term fluc-
tuation in psychophysical testing  [11] , and due to the non-
linear character of progression in the anatomic struc-
tures, e.g. excavation in optic nerve head  [12] .
 Earlier studies, using the pulsatile blood flow system 
according to Langham, tried to discriminate between 
healthy and glaucomatous  [13] eyes. These data cannot be 
Table 1. D istribution of gender, age, IOP based on Goldmann applanation tonometry, mean systemic blood pressure, and OPA of pa-
tients and controls
Glaucoma group Controls p value
Number of males 6 (55%) 0 0.011
Mean age 8 SD, years 67.1812.0 43.5811.2 <0.0012
IOP, mm Hg 18.883.9 18.382.3 0.75
Median 18.9 18.6
Interquartile range 15.2–21.8 16.4–20.0
System pressure, mm Hg 94.8830.0 81.6825.4 0.20
Median 92.3 81.5
Interquartile range 69.8–111.8 68.5–98.5
OPA3, mm Hg 3.67 2.99
Range 2.57–4.68 1.84–4.51
Comorbidities see table 2 none –
Medications see table 2 none –
1  Fisher’s exact test. 2 Wilcoxon rank-sum (Mann-Whitney) test. 3 1st component of the Fourier analysis.
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compared, since the ocular blood flow system is based on 
applanation of the cornea and thus influenced by, for ex-
ample, ocular rigidity and axial length. More recent data 
using DCT reveal a difference based solely on the OPA  [14] .
 Measuring the IOP and the OPA alone in our study 
does not reveal the difference between normal subjects 
and glaucoma patients ( table 1 ). However, when looking 
at the OPA in relation to the arterial pulsation, the differ-
ence becomes apparent. In our set-up, pulsation at the 
fingertip and at the eye was synchronized. This enabled 
us to compute the two waves, beat-to-beat, with each oth-
er. We have been able to show that the OPA, when con-
Table 2. O phthalmologic history, comorbidity and comedication
Sex Age
years
Ophthalmologic history Other illnesses Medication (local eye medication stopped 
2 weeks prior to study)
Male 75 bilateral NTG and high myopia polymyalgia rheumatica, systemic 
hypertension, diabetes, coronary 
artery disease
bimatoprostum, candesartanum, aspirin, 
gliclazidum, metformin, prednisone
Female 83 advanced bilateral POAG systemic hypertension dorzolamide + timolol, latanoprostum, 
lisinopril, binil
Male 71 bilateral NTG systemic hypertension latanoprostum, lisinopril, aspirin
Female 59 bilateral NTG systemic hypertension dorzolamide + timolol, latanoprostum,
candesartanum
Male 46 bilateral POAG, status after TE OS none timoptol, bimatoprostum
Male 61 bilateral POAG none dorzolamide + timolol, bimatoprostum
Female 69 bilateral pigmentary glaucoma systemic hypertension latanoprostum, candesartanum, carvedilol
Male 60 traumatic glaucoma none timoptol, latanoprostum
Female 82 advanced bilateral POAG arthritis brinzolamide, travatan
Female 78 bilateral exfoliation glaucoma none timoptol, latanoprostum
Male 54 bilateral POAG none latanoprostum













































































Ratio of amplitudes from Fourier analysis
AUC = 0.85 (95% Cl 0.66–1.00)
Ratio of SD of amplitudes
AUC = 0.81 (95% Cl 0.58–1.00)
 Fig. 2. Box plot distribution of standard deviations of the pres-
sure/pulse ratio for glaucoma patients and healthy controls. 
 Fig. 3. The discriminative capacity and diagnostic performance 
of the OPA. 
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sidered in relation to systemic pulsation, enables discrim-
ination.
 Our study has several limitations. One potential 
drawback of our investigation is that we did not match 
controls with respect to age and gender, and therefore 
possibly to their blood pressure. Due to the small num-
ber of subjects, we also decided to refrain from statistical 
correction for group imbalances. Furthermore, we as-
sumed that peripheral artery pulse wave signals, i.e. at 
the fingertip, and intraocular pulsation are comparable 
in all subjects. However, both the pulse wave itself and 
the vessel compliance may be different within one spe-
cific subject and between individuals, or between healthy 
(younger) volunteers and (elderly) eye patients. Further-
more, the impact of the methodological difference be-
tween OPA measurement and assessment of peripheral 
blood pressure using the Finapres technology on the 
study results is not known.
 Our data confirm the vascular character of the OPA, 
a parameter coming from the arterial pressure wave in 
the choroid. The eye modifies the incoming arterial pulse 
wave differently when glaucoma is present than when it 
is not.
 Our study design is advantageous in the early investi-
gation of a new diagnostic test  [15] . However, in order to 
explore its clinical usefulness, more upstream evaluations 
involving patients with suspected glaucoma are required.
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